Home Explore Sign in More

Maybelline New York TattooStudio Automatic Gel Pencil Eyeliner, 20 Midnight Mocha, 0.01 oz/280 mg

Product is rated SkinSAFE 100

Product is free of the top 11 most common allergens, as determined by Mayo Clinic Research

SkinSAFE 100
Learn More About SkinSAFE Ratings
Reviewed Ingredient information last updated on Aug 01, 2026 by SkinSAFE Team

Product is rated SkinSAFE 100

Product is free of the top 11 most common allergens, as determined by Mayo Clinic Research

SkinSAFE 100
Learn More About SkinSAFE Ratings
Reviewed Ingredient information last updated on Aug 01, 2026 by SkinSAFE Team

Other Formulations (0 products)

How Safe is It?

Product Is
Product Is Not

Unlock SAFE for Me™ and Safety Ratings

"Product is Not" Section – Exclusive to Premium Users. Discover why a product does not meet the criteria of a SkinSAFE marker and explore deeper product insights.

No commitment, cancel anytime.
Try for free
Have a promo code?

Ingredients

Description

Ingredient & Allergen Review

SkinSAFE has reviewed the ingredients of Maybelline New York TattooStudio Automatic Gel Pencil Eyeliner, 20 Midnight Mocha, 0.01 oz/280 mg and found it to be hypoallergenic and free of Fragrance, Gluten, Coconut, Nickel, Top Common Allergy Causing Preservatives, Lanolin, Paraben, Topical Antibiotic, MCI/MI, Soy, Propylene Glycol, Oil, Irritant/Acid, and SLS. Product is Lip Safe.

Product Description

Maybelline’s Tattoo Studio Automatic Gel Pencil is a mechanical, blendable gel liner. Get an easy eyeliner look with long-lasting tattoo matte finish. Up to 36-hour wear.

UPC

041554588934

Similar Products Show More

Q: are there any variants ?
A:

Thanks for your question. Any available product options or variants will appear through the Buy Now buttons on the product page. If no variants are shown there, we recommend reaching out to the brand directly to confirm whether additional options exist.

Have a question?
Report Incorrect Product Information

Incorrect Product Information

0/300
Success

Thank You!

Your feedback has been submitted. We'll review it shortly.

Error

Something Went Wrong

Please try again later or contact us.

Hang tight. We're thinking.